復星

Guo Guangchang’s empire under scrutiny as Fosun shares fall
復星股價下跌 郭廣昌的商業帝國引發關注

Hong Kong-listed Club Med owner downplays checks by Chinese regulators
自復星系公司宣佈減持復星醫藥股份以來,外界越來越關注復星集團400億美元的債務。

Fosun International shares have lost nearly one-fifth of their value this month since the announcement of the divestment of a core unit, putting the nearly $40bn of debt amassed by Chinese billionaire Guo Guangchang under increased scrutiny. Fosun International’s Hong Kong-listed shares closed at their lowest point since December 2012 on Wednesday after losing 18 per cent since September 2, the day the group announced the partial divestment of a core Chinese pharmaceutical unit.

自從復星國際(Fosun International)旗下一家核心子公司宣佈控股股東將減持股份以來,復星國際股價本月已下跌約五分之一,讓其創辦人、中國億萬富翁郭廣昌400億美元的債務受到更多審視。

您已閱讀12%(581字),剩餘88%(4306字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×